Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Preston Mason

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Sub-Cellular Biochemistry|July 7, 2007
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAidsR Preston Mason, Mary F Walter, Charles A Day, et al.
Biochemical Pharmacology|October 14, 2003
Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and ruptureYong-Jian Geng, Jane Ellen Phillips, R Preston Mason, et al.
The American Journal of Cardiology|August 30, 2005
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actionsR Preston Mason, Mary F Walter, Charles A Day, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2017
Metformin treatment decreases nitroxidative stress, restores nitric oxide bioavailability and endothelial function beyond glucose controlTakehiko Sambe, R Preston Mason, Hazem Dawoud, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2022
A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomesSamuel C R Sherratt, Peter Libby, Deepak L Bhatt, et al.
The Journal of Biological Chemistry|February 9, 2006
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanismR Preston Mason, Mary F Walter, Charles A Day, et al.
Journal of Cardiovascular Pharmacology|April 12, 2013
Atorvastatin active metabolite inhibits oxidative modification of small dense low-density lipoproteinRobert F Jacob, Mary F Walter, Yehudi Self-Medlin, et al.
American Journal of Hypertension|October 31, 2013
Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changesR Preston Mason, Robert F Jacob, J Jose Corbalan, et al.
Circulation|December 7, 2005
Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black AmericansR Preston Mason, Leszek Kalinowski, Robert F Jacob, et al.
Biochimica Et Biophysica Acta|April 21, 2009
Glucose promotes membrane cholesterol crystalline domain formation by lipid peroxidationYehudi Self-Medlin, Jungsoo Byun, Robert F Jacob, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Sub-Cellular Biochemistry|July 7, 2007
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAidsR Preston Mason, Mary F Walter, Charles A Day, et al.
Biochemical Pharmacology|October 14, 2003
Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and ruptureYong-Jian Geng, Jane Ellen Phillips, R Preston Mason, et al.
The American Journal of Cardiology|August 30, 2005
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actionsR Preston Mason, Mary F Walter, Charles A Day, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2017
Metformin treatment decreases nitroxidative stress, restores nitric oxide bioavailability and endothelial function beyond glucose controlTakehiko Sambe, R Preston Mason, Hazem Dawoud, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2022
A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomesSamuel C R Sherratt, Peter Libby, Deepak L Bhatt, et al.
The Journal of Biological Chemistry|February 9, 2006
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanismR Preston Mason, Mary F Walter, Charles A Day, et al.
Journal of Cardiovascular Pharmacology|April 12, 2013
Atorvastatin active metabolite inhibits oxidative modification of small dense low-density lipoproteinRobert F Jacob, Mary F Walter, Yehudi Self-Medlin, et al.
American Journal of Hypertension|October 31, 2013
Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changesR Preston Mason, Robert F Jacob, J Jose Corbalan, et al.
Circulation|December 7, 2005
Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black AmericansR Preston Mason, Leszek Kalinowski, Robert F Jacob, et al.
Biochimica Et Biophysica Acta|April 21, 2009
Glucose promotes membrane cholesterol crystalline domain formation by lipid peroxidationYehudi Self-Medlin, Jungsoo Byun, Robert F Jacob, et al.
Pageof 10